VISCO360 VISCOSURGICAL SYSTEM
Report
- Report Number
- 3010363671-2017-00001
- Event Type
- Injury
- Date Received
- February 20, 2017
- Date of Event
- January 21, 2017
- Report Date
- January 25, 2017
- Manufacturer
- SIGHT SCIENCES, INC.
- Product Code
- MRH
- UDI-DI
- 00858027006013
- PMA / PMN Number
- K143205
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OR, US
- Reporter Occupation
- PHYSICIAN
Narratives
ALL PERTINENT INFORMATION AVAILABLE TO SIGHT SCIENCES, INC. HAS BEEN SUBMITTED. THE COMPANY IS SUBMITTING THIS MDR TO ENSURE FULL COMPLIANCE WITH 21 CFR PART 803. THE DEVICE WAS DISCARDED BY THE FACILITY AND IS NOT AVAILABLE FOR EVALUATION. THE DEVICE HISTORY RECORDS (MANUFACTURING AND STERILIZATION) WERE REVIEWED AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS THAT RELATE TO THE REPORTED EVENT. (B)(4).
ON (B)(6) 2017, THE PATIENT HAD UNEVENTFUL CATARACT SURGERY FOLLOWED BY VASODILATION OF SCHLEMM'S CANAL IN THE LEFT EYE. TWO DAYS POSTOPERATIVELY THE PATIENT WAS DIAGNOSED WITH TASS WITH ASSOCIATED ANTERIOR CHAMBER INFLAMMATION, HYPOPYON, INCREASED WHITE BLOOD CELLS IN THE ANTERIOR CHAMBER, AND DECREASED VISUAL ACUITY. PREOPERATIVELY, THE PATIENT'S BEST CORRECTED VISUAL ACUITY (BCVA) WAS 20/40; AT ONSET, BCVA DECREASED TO 20/100 AND IOP WAS MEASURED AT 14 MMHG. THE PATIENT WAS TREATED WITH TOPICAL STEROIDS, TOPICAL ANTIBIOTICS, AND AN INTRAVITREAL INJECTION. THE EYE WAS CULTURED AND RESULTS WERE NEGATIVE FOR BACTERIA AND FUNGUS. ON FEBRUARY 16, 2017, THE DOCTOR REPORTED THAT THE PATIENT WAS FULLY RECOVERED WITH AN UNCORRECTED VISUAL ACUITY OF 20/50 AND A PINHOLE ACUITY OF 20/30. THERE HAVE BEEN NO OTHER REPORTS OF TASS AT THIS SURGICAL FACILITY AND THE ASSOCIATION BETWEEN THE EVENT AND THE DEVICE IS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 125382 | VISCO360 VISCOSURGICAL SYSTEM | VISCOELASTIC INJECTOR | MRH | SIGHT SCIENCES, INC. | 03916 | 1005195 | 00858027006013 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Required Intervention | CATARACT SURGERY| HEALON GV USED IN VISCO360 DEVICE |